Avonex interferon beta-1a: Completed Phase IV enrollment

Biogen Idec completed enrollment of 136 patients in the open-label, U.S. Phase IV ASSURANCE trial evaluating Avonex for 15 years. Patients enrolled in the study were previously treated for at least 2 ...